Picture of iTeos Therapeutics logo

ITOS — iTeos Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Brief: Iteos Therapeutics Inc - Cash And Investment Balance Of $731.4Mm As Of December 31, 2022, Expected To Provide Runway Into 2026

March 15 (Reuters) - Iteos Therapeutics Inc  ITOS.O :
    * ITEOS THERAPEUTICS INC - CASH AND INVESTMENT BALANCE OF
$731.4MM
AS OF DECEMBER 31, 2022, EXPECTED TO PROVIDE RUNWAY INTO 2026
    * ITEOS THERAPEUTICS INC - EOS-984 EXPECTED TO ENTER
CLINICAL
STUDIES IN MID-2023
    * ITEOS THERAPEUTICS INC -  CASH, CASH EQUIVALENTS AND
INVESTMENTS
POSITION WAS $731.4 MILLION AS OF DECEMBER 31, 2022
    * ITEOS THERAPEUTICS INC- QTRLY NET INCOME ATTRIBUTABLE TO
COMMON
SHAREHOLDERS WAS $20.5 MILLION, OR A NET INCOME OF $0.54 OF PER
DILUTED SHARE

Source text for Eikon:  ID:nGNEkDGnW 
Further company coverage:  ITOS.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on iTeos Therapeutics

See all news